Schedules of controlled substances: placement of lacosamide into schedule V. Final rule.
With the issuance of this final rule, the Deputy Administrator of the DEA places the substance lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide] and any material, compound, mixture, or preparation which contains any quantity of lacosamide into schedule V of the Controlled Substances Act (CSA). As a result of this rule, the regulatory controls and criminal sanctions of schedule V will be applicable to the manufacture, distribution, dispensing, importation and exportation of lacosamide.
D000081:Acetamides / Q000145:classification* / Q000627:therapeutic use; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D014481:United States
D000081:Acetamides